Wearable Injectors Market

Wearable Injectors Market - Global Market Share, Trends, Analysis and Forecast, 2023-2032
Frequently asked questions about this report

The global wearable injectors market is estimated to exhibit a CAGR of 11.5% between 2023 to 2032.

Due to the obvious rising prevalence of chronic and lifestyle-related illnesses and the modernization of the healthcare system, North America is the biggest market by region, accounting for 41.5% of the overall industry share.

Increased prevalence of chronic disorders such as pulmonary arterial hypertension, cardiovascular disease, cancer, Type 1 diabetes, rheumatoid arthritis, and autoimmune diseases along with other neurological diseases is increasing the growth of the Global Wearable Injectors Market.

The wearable injectors market size was estimated to be US$ 6.3 billion in 2021.

Major players in the global wearable injectors market are Amgen, Inc., Becton, CeQur SA, Dickinson and Company, Johnson & Johnson Services, Inc., Enable Injections, F. Hoffmann-La Roche Ltd., Insulet Corporation, Unilife Corporation, SteadyMed Therapeutics, Inc., West Pharmaceutical Services, Inc., and Ypsomed.

Due to the rising demand for user-friendly adhesive patches that allow patients to inject the drug subcutaneously, rapidly, and precisely by clicking on the device, the spring-based category has the greatest market size by technology.